Skip to Content
David F. Schneider, MD, MS

Surgical Services

Contact Dr. Schneider


(608) 263-1387

MADISON, WI 53792-3284

David F. Schneider, MD, MS

Assistant Professor
Section of Endocrine Surgery
Division of General Surgery


  • MD, Loyola Stritch School of Medicine, Chicago, IL, 2004
  • Research Fellowship in Burn & Shock Trauma, Loyola Medical Center, Chicago, IL, 2008
  • MS in Clinical Research Methods, Department of Preventive Medicine & Epidemiology, Loyola Stritch School of Medicine, 2010
  • General Surgery Residency, Loyola Medical Center, Chicago, IL, 2011
  • Fellowship in Endocrine Surgery, University of Wisconsin School of Medicine and Public Health, 2013

Clinical Specialties

Dr. Schneider is certified by the American Board of Surgery, and he is a member of multiple specialty societies including the American Association of Endocrine Surgeons, the American Thyroid Association, the North American NeuroEndocrine Tumor Society, and the American Association of Clinical Endocrinologists. He specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands. He utilizes several minimally invasive techniques to treat endocrine disorders (endoscopic thyroidectomy, minimally invasive parathyroidectomy, laparoscopic adrenalectomy, focused exploration for recurrent thyroid cancer).

Dr. Schneider provides a wide range of services including Adrenalectomy, Laparoscopic, Adrenalectomy, Open, Adrenal Surgery, Central Neck Dissection, Endocrine Surgery, Fine Needle Aspiration (FNA), Minimally Invasive Parathyroidectomy, Minimally Invasive Radioguided Parathyroidectomy (MIRP), Modified Radical Neck Dissection, Neck Ultrasound, Parathyroid Surgery, Resection Of Substernal Goiter, Subtotal Parathyroidectomy, Thyroidectomy, Thyroid Lobectomy, Thyroid Surgery, and Total Thyroidectomy.

Research Interests

Dr. Schneider conducts outcomes research in conjunction with the Wisconsin Surgical Outcomes Program. His research program investigates the optimization of cancer care in the United States with a particular interest in endocrine cancers. This work utilizes large national databases which can impact national healthcare and policy initiatives. He also conducts clinical research working on hyperparathyroidism, thyroid cancer, Graves’ Disease, and adrenal disorders.

Recent Publications
  • Is intraoperative parathyroid hormone testing in┬ápatients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate?
    Sohn JA, Oltmann SC, Schneider DF, Sippel RS, Chen H, Elfenbein DM
    Am. J. Surg. 2015 Mar; 209(3):483-7.
    [PubMed ID: 25556028, PMC ID: 4361237]
    More Information
  • Is central lymph node dissection necessary for parathyroid carcinoma?
    Hsu KT, Sippel RS, Chen H, Schneider DF
    Surgery 2014 Dec; 156(6):1336-41; discussion 1341.
    [PubMed ID: 25456903, PMC ID: 4254726]
    More Information
  • The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy.
    Somnay YR, Weinlander E, Schneider DF, Sippel RS, Chen H
    Surgery 2014 Dec; 156(6):1308-13; discussion 1313-4.
    [PubMed ID: 25456900, PMC ID: 4254721]
    More Information
  • Clinical and socioeconomic factors influence treatment decisions in graves' disease.
    Elfenbein DM, Schneider DF, Havlena J, Chen H, Sippel RS
    Ann. Surg. Oncol. 2015 Apr; 22(4):1196-9.
    [PubMed ID: 25245130, PMC ID: 4346454]
    More Information
  • Outcomes after subtotal parathyroidectomy for primary hyperparathyroidism due to hyperplasia: significance of whole vs. partial gland remnant.
    Rajaei MH, Oltmann SC, Schneider DF, Sippel RS, Chen H
    Ann. Surg. Oncol. 2015 Mar; 22(3):966-71.
    [PubMed ID: 25245126, PMC ID: 4330105]
    More Information
  • All thyroid ultrasound evaluations are not equal: sonographers specialized in thyroid cancer correctly label clinical N0 disease in well differentiated thyroid cancer.
    Oltmann SC, Schneider DF, Chen H, Sippel RS
    Ann. Surg. Oncol. 2015 Feb; 22(2):422-8.
    [PubMed ID: 25234019, PMC ID: 4330103]
    More Information
  • Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study.
    Oltmann SC, Brekke AV, Schneider DF, Schaefer SC, Chen H, Sippel RS
    Ann. Surg. Oncol. 2015 Mar; 22(3):952-8.
    [PubMed ID: 25212835, PMC ID: 4318765]
    More Information
  • CaPTHUS Scoring Model in Primary Hyperparathyroidism: Can It Eliminate the Need for ioPTH Testing?
    Elfenbein DM, Weber S, Schneider DF, Sippel RS, Chen H
    Ann. Surg. Oncol. 2015 Apr; 22(4):1191-5.
    [PubMed ID: 25212837, PMC ID: 4346409]
    More Information
  • Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism.
    Rajaei MH, Bentz AM, Schneider DF, Sippel RS, Chen H, Oltmann SC
    Ann. Surg. Oncol. 2015 Feb; 22(2):454-9.
    [PubMed ID: 25192677, PMC ID: 4297226]
    More Information
  • Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.
    Schneider DF, Elfenbein D, Lloyd RV, Chen H, Sippel RS
    Ann. Surg. Oncol. 2015 Jan; 22(1):158-63.
    [PubMed ID: 25092163, PMC ID: 4275358]
    More Information Copyright © 2015 The Board of Regents of the University of Wisconsin System